Brain-Derived Neurotrophic Factor and Antidepressant Activity

By  

Current Pharmaceutical Design, Vol. 11, Iss. 12, 2005-05 ,pp. : 1495-1510

Bentham Science Publishers

Access to resources Recommend Favorite

Role of Brain-Derived Neurotrophic Factor in the Aetiology of Depression: Implications for Pharmacological Treatment

By Castrén Eero   Rantamäki Tomi  

CNS Drugs, Vol. 24, Iss. 1, 2010-01 ,pp. : 1-7

Adis International

Access to resources Recommend Favorite

Pharmacogenetics of Selective Serotonin Reuptake Inhibitor Response in Major Depression

By  

Current Pharmacogenomics, Vol. 1, Iss. 1, 2003-03 ,pp. : 1-7

Bentham Science Publishers

Access to resources Recommend Favorite

Effect of Brain-Derived Neurotrophic Factor (BDNF) Gene Variants on the Therapeutic Response and the Risk for Mood Disorders

By  

Current Pharmacogenomics and Personalized Medicine (Formerly Current Pharmacogenomics), Vol. 6, Iss. 2, 2008-06 ,pp. : 126-133

Bentham Science Publishers

Access to resources Recommend Favorite

A randomised, double‐blind study in adults with major depressive disorder with an inadequate response to a single course of selective serotonin reuptake inhibitor or serotonin–noradrenaline reuptake inhibitor treatment switched to vortioxetine or agomelatine†

By  

Human Psychopharmacology: Clinical And Experimental (Electronic), Vol. 30, Iss. 4, 2015-07 ,pp. : 327-327

John Wiley & Sons Inc

Access to resources Recommend Favorite